The Daily Update - Disrupting the US healthcare industry

An investment bank, an online retailer and a conglomerate walk into a bar and ask for a cocktail called a ‘healthcare policy’ that is simple, transparent and reasonably priced. The bartender says, ‘Sorry we’ve only ever served ‘em complicated, murky and expensive’... So the three punters walked out and mixed one up themselves.

This pretty much sums up yesterday’s announcement that JPMorgan, Amazon and Berkshire Hathaway (the three unhappy punters) plan to set up a non-profit healthcare company. It is a welcome initiative that combines the complementary forces of three heavyweight US corporates to address ‘The ballooning costs of healthcare [which] act as a hungry tapeworm on the American economy’ according to Warren Buffett of Berkshire Hathaway. Although it was clearly not welcomed by many healthcare stocks which fell between 3% and 11% on the news (and a general sell-off in stocks), along with some big brand pharmaceuticals who could face the bargaining power and disruptive forces that the likes of Amazon are well known for.

Mr Buffett contended further, ‘we share the belief that putting our collective resources behind the country’s best talent can, in time, check the rise in health costs while concurrently enhancing patient satisfaction and outcomes’. Their plans will, at least initially, address their combined almost 1 million US employees but those that have anticipated Amazon’s move into the healthcare industry for some time now expect that the future implications of this announcement will be much wider. JPMorgan CEO Jamie Dimon affirmed this view stating, ‘The three of our companies have extraordinary resources, and our goal is to create solutions that benefit our U.S. employees, their families and, potentially, all Americans’.

According to the FT, ‘Annual premiums for employer-sponsored family health coverage reached $18,764 last year, up 3 per cent from 2016’. For now the venture is expected to start simple, reducing costs using big data analytics, but given these companies’ complementary, technical, financial and insurance expertise it might only be a few years until they craft a full-fledged alternative to the current exorbitant private costs and uncertain public healthcare protections.

Please read this important information before proceeding. It contains legal and regulatory notices relevant to the information on this site.

This website provides information about Stratton Street Capital LLP ("Stratton Street"). Stratton Street is authorised and regulated by the UK's Financial Conduct Authority. The content of this website has been prepared by Stratton Street from its records and is believed to be accurate but we do not accept any liability or responsibility in respect of the information of any views expressed herein. The information, material and content provided in the pages of this website may be changed at any time by us. Information on this website may be out of date and may not be updated or removed.

The website is provided for the main purpose of providing generic information on Stratton Street and on our investment philosophy for the use of financial professionals in the United Kingdom that qualify as Professional Clients or Eligible Counterparties under the rules of the United Kingdom Financial Conduct Authority (the "FCA"). The information in this website is not intended for the use of and should not be relied on by any person who would qualify as a Retail Client. Products and services referred to on this website are offered only at times when, and in jurisdictions where, they may be lawfully offered. The information on this website is not directed to any person in the United States. The provision of the information on this website does not constitute an offer to purchase securities to any person in the United States (other than a professional fiduciary acting for the account of a non-U.S person) or to any U.S. person as such term is defined under the Securities Act of 1933, as amended.

The website is not intended to offer investors the opportunity to invest in any Alternative Investment Fund ("AIF") product. The AIFs managed by Stratton Street are not being marketed in the European Economic Area ("EEA") and any eligible potential investor from the EEA who wishes to obtain information on the AIFs will only be provided with materials upon receipt by Stratton Street of an appropriate reverse solicitation request in accordance with the requirements of the EU Alternative Investment Fund Managers Directive ("AIFMD") and national law in their home jurisdiction. By proceeding you confirm that you are not accessing this website in the context of a potential investment by an EEA investor in the AIFs managed by Stratton Street and that you have read, understood and agree to these terms.

No information contained in this website should be deemed to constitute the provision of financial, investment or other professional advice in any way. The website should not be relied upon as including sufficient information to support any investment decision. If you are in doubt as to the appropriate course of action we recommend that you consult your own independent financial adviser, stockbroker, solicitor, accountant or other professional adviser. Past performance is not necessarily a guide to the future. The value of investments and the income from them may go down as well as up. An application for any investment or service referred to on this site may only be made on the basis of the offer document, key features, prospectus or other applicable terms relating to the specific investment or service.

Where we provide hypertext links to other locations on the Internet, we do so for information purposes only. We are not responsible for the content of any other websites or pages linked to or linking to this website. We have not verified the content of any such websites. Such websites may contain products and services that are not authorised in your jurisdiction. Following links to any other websites or pages shall be at your own risk and we shall not be responsible or liable for any damages or in other way in connection with linking.

By using this site, you should be aware that we may disclose any information that we hold about you to any regulatory authority to which we are subject, or to any person legally empowered to require such information.

This website uses cookies to improve user experience, by clicking the "I Accept" button below means you consent to the use of cookies on our website.